Cite
HARVARD Citation
Ghorashian, S. et al. (2022). Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study. Lancet. 9 (10), pp. e766-e775. [Online].